KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Gross Profit: 2010-2024

Historic Gross Profit for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $767.6 million.

  • Emergent BioSolutions' Gross Profit fell 15.19% to $145.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.9 million, marking a year-over-year decrease of 8.45%. This contributed to the annual value of $767.6 million for FY2024, which is 3.21% up from last year.
  • As of FY2024, Emergent BioSolutions' Gross Profit stood at $767.6 million, which was up 3.21% from $743.7 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Gross Profit registered a high of $1.0 billion during FY2020, and its lowest value of $743.7 million during FY2023.
  • For the 3-year period, Emergent BioSolutions' Gross Profit averaged around $786.8 million, with its median value being $767.6 million (2024).
  • Per our database at Business Quant, Emergent BioSolutions' Gross Profit surged by 41.79% in 2020 and then decreased by 17.21% in 2022.
  • Emergent BioSolutions' Gross Profit (Yearly) stood at $1.0 billion in 2020, then dropped by 1.42% to $1.0 billion in 2021, then decreased by 17.21% to $849.0 million in 2022, then fell by 12.40% to $743.7 million in 2023, then grew by 3.21% to $767.6 million in 2024.